Dr. Michele A. Nedelka, MD

Dr. Nedelka practices at Bon Secours Harbour View Medical Center in Suffolk, Virginia, part of Bon Secours Mercy Health.

Dr. Nedelka's NPI, 1003079138, was assigned on July 9, 2008. Dr. Nedelka graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2008. Dr. Nedelka's Texas license number on file is P7521.

Dr. Nedelka's primary practice is Bon Secours Harbour View Medical Center, at 1020 Bon Secours Drive, Suffolk, VA 23435 in Suffolk City. The practice phone is (757) 673-5917.

Dr. Nedelka's primary practice is Bon Secours Harbour View Medical Center in Suffolk, Virginia, part of Bon Secours Mercy Health. Dr. Nedelka is also affiliated with Sentara Obici Hospital. The medical group on file is Bon Secours Hampton Roads Medical Group. Dmand AI also links Dr. Nedelka to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nedelka practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Nedelka's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Nedelka is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Nedelka's licenses on file in 2 states: Texas and Virginia.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Nedelka treats.

CMS data shows 3,206 Medicare services from Dr. Nedelka across 18 procedure codes in 2024, for 399 Medicare patients. Medicare paid $223,848 for them. Every service was in an office.

CMS counts 399 Medicare patients who saw Dr. Nedelka in 2024. The largest group is 75 to 84, with 184 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nedelka's median patient age at 72, with 46% women.

In 2024, Dr. Nedelka wrote 83 Medicare Part D claims for 40 patients. 100% of them were for generic drugs. CMS names the drug for 63 of them, across 1 drug with 11 or more claims each, at $682 in total drug cost. In 2023, CMS named 101 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Nedelka for performance year 2024, reported individually. Dr. Nedelka accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Nedelka, published from 2014 to 2015. 2015 was the busiest year, with 2. Dr. Nedelka's most frequent co-authors are Alberto Broniscer, MD, Amar J. Gajjar, MD and Siddharth Ajaybhai Saraiya, MD.

Dmand AI links Dr. Nedelka to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 24 general payments to Dr. Nedelka from 11 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. IsoRay, Inc paid the most, $267.

Dr. Nedelka serves on Board of Directors Virginia Breast Cancer Foundation.

Dr. Nedelka graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2008. Dr. Nedelka is a member of AOA, AAPL, American Brachytherapy Society, ACR, AMA and ASTRO.

Dr. Nedelka is in network with 15 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.